Article

HER2 Evaluation in Uterine Serous Carcinoma: Diagnostic Agreement Between Biopsy and Resection Samples

2025-11-13

Abstract excerpt

<title>Abstract</title> <p>Background Uterine serous carcinoma (USC) is a very aggressive variant of endometrial cancer, contributing to a disproportionate incidence of recurrences and cancer-related mortality, albeit representing a minority of cases. HER2 overexpression and amplification have become important prognostic and predictive indicators in USC, endorsing the application of HER2-targeted treatments. None...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5ce0c0c2-d78c-5a22-beb1-c4753eec9bbe
DOI: 10.21203/rs.3.rs-7820482/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

HER2 Evaluation in Uterine Serous Carcinoma: Diagnostic Agreement Between Biopsy and Resection SamplesDOI 10.21203/rs.3.rs-7820482/v1Read

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas.Semantic proximity Read

The comparison of pure uterine serous carcinoma and mixed tumor with serous component：A Single-Institution Review of 91 CasesSemantic proximity Read

Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma: Implications for Clinical HER2 Testing and InterpretationSemantic proximity Read

Mapping evidence and gaps in diagnostic characteristics of endometrial carcinomas of the uterine corpus: implications for the WHO Classification of tumours, research, and clinical practiceSemantic proximity Read

The Rapidly Evolving Landscape of Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Endometrial Carcinoma and Other Gynecologic Malignancies.Semantic proximity Read

Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.Semantic proximity Read

Detection of ERBB2 amplification in uterine serous carcinoma by next-generation sequencing: an approach highly concordant with standard assaysSemantic proximity Read

Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.Semantic proximity Read

Untitled literature recordSemantic proximity Read

Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer.Semantic proximity Read

[Endometrial carcinomas in 2021: What to say and what to do?]Semantic proximity Read

Validation of molecular classification on diagnostic biopsy in endometrial carcinoma: the first step for a tailored approach.Semantic proximity Read